Assessment of Tumor Regression by Consecutive Pelvic Magnetic Resonance Imaging and Dose Modification during High-Dose-Rate Brachytherapy for Carcinoma of the Uterine Cervix

PURPOSE: To assess tumor regression, as determined by pelvic magnetic resonance imaging (MRI), and evaluate the efficacies and toxicities of the interim brachytherapy (BT) modification method, according to tumor regression during multi-fractionated high-dose-rate (HDR) BT for uterine cervical cancer...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Nam, Taek-Keun, Nah, Byung-Sik, Choi, Ho-Sun, Chung, Woong-Ki, Ahn, Sung-Ja, Kim, Seok-Mo, Song, Ju-Young, Yoon, Mi-Seon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Cancer Association 2005
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2785406/
https://ncbi.nlm.nih.gov/pubmed/19956497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2005.37.3.157
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia